Risk reduction was also found for neurocognitive disorders like Alzheimer’s and dementia ... by more narrowly focused studies ...

Obstructive Sleep Apnea (OSA) is a common sleep disorder in children characterized ... can lead to various health issues, including neurocognitive impairments and behavioral problems.

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...

A new study shows that GLP-1 drugs offer health benefits such as reducing risks for heart disease but also carry potential risks like gastrointestinal issues.

Home Bladder Cancer Test: New Urine-Based Kit May Enable Early DiagnosisThe research team has developed a urine-based ...

Women are at a 31% higher risk of developing long Covid compared to men, with those aged 40-55 being the most affected. Long ...

Mild cognitive impairment (MCI ... However, in another work, a similar pattern of expression was observed in patients with HIV-associated neurocognitive disorder, where the levels of hsa-miR-149-3p ...

Of note, validity test failure is particularly likely in moderate and severe TBI, and both mild and moderate-to-severe dementia (where the ‘severe impairment’ profile on the WMT often applies). Of ...

GLP-1RA use vs usual care was significantly associated with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimer disease and dementia ...

For pediatric insomnia, Dr Umakanth Katwa and Dr Rafael Pelayo call for a blend of clinical expertise, behavioral therapy, and empathy.

(HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine ...